Keyword Suggestion
Domain Informations
Actemra.com lookup results from whois.safenames.net server:
- Domain created: 2003-04-17T09:58:26Z
- Domain updated: 2024-05-01T02:20:46Z
- Domain expires: 2026-04-17T09:58:26Z 0 Years, 100 Days left
- Website age: 22 Years, 265 Days
- Registrar Domain ID: 96917932_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.9.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.9.222)
Spam Check (IP: 104.18.9.222)
Recent Searched Sites
› Behzen.com (2 seconds ago) / DE
› Tophatsupply.com (7 seconds ago) / US
› Curanda.org (2 seconds ago) / DE
› Xpansion.com.au (1 seconds ago) / US
› Xcheat.gg (1 seconds ago) / US
› Upecotourism.in (2 seconds ago) / US
› Outdooretc.com (3 seconds ago) / US
› Barpecora.com (5 seconds ago) / US
› Sams-geo.com (2 seconds ago) / US
› Moralinjurypoetry.com (2 seconds ago) / US
› Support.heimdalsecurity.com (10 seconds ago) / US
› Myhealthcar.com (5 seconds ago) / US
› Bellprints.com (5 seconds ago) / US
› Actemra.com (1 seconds ago) / US
› Ladertechnik.com (4 seconds ago) / DE
› Xmail.tesla.com (1 seconds ago) / US
› Exceedlms.com (7 seconds ago) / US
› Pcpsct.org (3 seconds ago) / US
› Tcclex.com (9 seconds ago) / IT
› Guestoo.cloud (1 seconds ago) / DE
Websites Listing
We found Websites Listing below when search with actemra.com on Search Engine
Important Safety Information on ACTEMRA® (tocilizumab ...
ACTEMRA (tocilizumab): 20 mg/mL concentrate solution for intravenous infusion (IV) in 4 mL, 10 mL, and 20 mL vials, and 162 mg/0.9 mL solution for subcutaneous (SC) injection. Background information . ACTEMRA has market authorization in Canada for use in the following indications: 1. Rheumatoid Arthritis [IV or SC formulations] ACTEMRA is indicated for reducing signs and …
Recalls-rappels.canada.caActemra Shortage: What to Do If You Can’t Access Tocilizumab
2021-09-07 · Actemra is known as an interleukin-6 (IL-6) blocker. IL-6 is an immune system protein that plays a role in inflammation. The medication works by blocking receptors for IL-6 on cells, which reduces the inflammation. This helps to decrease arthritis joint pain and swelling, and other symptoms caused by inflammation.
Creakyjoints.orgPRODUCT MONOGRAPH - Roche Canada
ACTEMRA is indicated for the treatment of patients with chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome (CRS), in accordance with patient populations specified for authorized CAR T cell products. Pediatrics (< 18 years of age): The safety and efficacy in patients aged less than 2 years in sJIA and pJIA have not been …
Rochecanada.comActemra (Tocilizumab) Shortage Is Still Affecting ...
2022-01-19 · If you would like to share your concerns or story about accessing Actemra, please email Patient Advocate and Community Outreach Manager Zoe Rothblatt. Genentech, which manufactures Actemra (tocilizumab), and Sanofi, which makes Kevzara (sarilumab), are sponsors of the Global Healthy Living Foundation. They do not provide input on the editorial …
Creakyjoints.orgGenentech: Purchasing Actemra
PURCHASING ACTEMRA. (tocilizumab) Current as of March 2022. Please note: We are reviewing this page weekly and information is updated as relevant or necessary. If you are a patient seeking information on Actemra IV or SC please contact our Patient Resource Center at (877-436-3683). Thank you for your continued patience as Genentech works to ...
Gene.comActemra (tocilizumab) | pCPA
2018-07-26 · Actemra (tocilizumab) pCPA File Number: 21030 Negotiation Status: Concluded with an LOI Indication(s): Giant Cell Arteritis Sponsor/Manufacturer: Hoffmann-La Roche CADTH Project Number: SR0534-000 pCPA Engagement Letter Issued: 2018-07-26. Negotiation Process Concluded: 2018-12-06. About pCPA. Who We Are; Governance; Strategic Plan; FAQs; …
Pcpacanada.caActemra - healthdirect
Subcutaneous formulation Actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 1 year of age and older.Actemra IV and SC can be given alone or in combination with methotrexate (MTX).,Cytokine Release Syndrome (CRS) (IV formulation only), Actemra is indicated for the treatment of chimeric antigen receptor (CAR) T cell-induced …
Healthdirect.gov.auDosing Calculator for RA Treatment | ACTEMRA® (tocilizumab)
In the ACTEMRA-IV monotherapy clinical study, the rate of serious infections was 3.6 per 100 patient-years in the ACTEMRA group and 1.5 per 100 patient-years in the methotrexate group. The rate of serious infections in the 4 mg/kg and 8 mg/kg ACTEMRA plus DMARD groups was 4.4 and 5.3 events per 100 patient-years, respectively, compared to 3.9 events per 100 patient …
Actemrahcp.comRoche (Genentech) - Actemra®(tocilizumab)
2020-05-18 · Candidate: Actemra® (tocilizumab) Type: Interleukin-6 (IL-6) receptor antagonist approved by the FDA in 2010, with indications in rheumatoid …
Genengnews.comACTEMRA: Side Effects, Reviews by Patients - AskaPatient.com
Email: 5: GCA: Don't have any that I know about. Was on 60 mg. Predisone for over a yr. before weaning down & have been off for 4 months. Total time on Predisone about 20 months & on Actemra for 14 months - 10 more months to go. I lost vision in right eye, but things are looking good & Actemra makes me feel confident it won't come back. The ...
Askapatient.comwww.theglobeandmail.com
301 Moved Permanently. openresty
Theglobeandmail.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| dbuilderstore.com | godaddy.com | -3 Years, -45 Days |
| maxsurf.net | ionos.com | -1 Years, -43 Days |
| bluesquareyachts.com | godaddy.com | -3 Years, -291 Days |
| theaba.org | networksolutions.com | -1 Years, -287 Days |
| galeriawschod.com | netart-registrar.com | -3 Years, -134 Days |
| cnft.tools | namecheap.com | -3 Years, -152 Days |
| tsars.com | godaddy.com | -3 Years, -253 Days |
| wshang.com | net.cn | -3 Years, -48 Days |
| doramaclub.net | godaddy.com | -3 Years, -76 Days |
| abcnbs.com | godaddy.com | -2 Years, -9 Days |